acute leukemia

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Houston (SNDX-5613)

Recruiting
  • Acute Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 3, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • TregGraft (Orca-T)
  • Duarte, California
  • +13 more
Oct 28, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (OrcaGraft (Orca-Q))

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • OrcaGraft (Orca-Q)
  • Duarte, California
  • +7 more
Oct 28, 2021

Bone Marrow Transplant Infection, Infection in Marrow Transplant Recipients, Respiratory Syncytial Virus Infections Trial in

Completed
  • Bone Marrow Transplant Infection
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 21, 2021

Acute Leukemia Trial in United States (LY2523355)

Terminated
  • Acute Leukemia
  • Chicago, Illinois
  • +4 more
May 10, 2019

Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

Completed
  • Acute Leukemia
  • +8 more
  • Tacrolimus (ARM with Methotrexate)
  • +7 more
  • Duarte, California
  • +29 more
Jan 2, 2019

Acute Leukemia Trial in Rochester, Houston (PM01183 1 mg Powder for concentrate for solution for infusion and PM01183 4 mg

Completed
  • Acute Leukemia
  • PM01183 1 mg Powder for concentrate for solution for infusion and PM01183 4 mg Powder for concentrate for solution for infusion
  • Rochester, Minnesota
  • +1 more
Nov 4, 2015

Acute Leukemia, Chronic Myeloproliferative Disease, Chronic Lymphoproliferative Disease Trial in Houston (ZIO-101

Completed
  • Acute Leukemia
  • +5 more
  • ZIO-101 (Darinaparsin)
  • Houston, Texas
    (unnamed)
Jul 18, 2012